https://www.moneycontrol.com/news/business/ipo/jhunjhunwalas-rare-trusts-backed-concord-biotech-ipo-booked-16-on-debut-11097741.html
Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer.
Create an account or login to join the discussion